{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:14:29Z","timestamp":1775978069002,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD14\/00002"],"award-info":[{"award-number":["CD14\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD13\/00013"],"award-info":[{"award-number":["CD13\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP14\/0010"],"award-info":[{"award-number":["CP14\/0010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP14\/00198"],"award-info":[{"award-number":["CP14\/00198"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0017\/0024"],"award-info":[{"award-number":["RD12\/0017\/0024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0017\/0031"],"award-info":[{"award-number":["RD12\/0017\/0031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["MPY 1404\/15"],"award-info":[{"award-number":["MPY 1404\/15"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14CIII\/00011"],"award-info":[{"award-number":["PI14CIII\/00011"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-1005-7","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T09:50:21Z","timestamp":1472809821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV\/HCV coinfected patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Luz M.","family":"Medrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Rall\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ald\u00e1miz-Echevarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcial","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Tejerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0450","authenticated-orcid":false,"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u201368.","journal-title":"J Hepatol"},{"key":"1005_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","volume":"48","author":"HH Thein","year":"2008","unstructured":"Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48:418\u201331.","journal-title":"Hepatology"},{"key":"1005_CR3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0b013e3283454174","volume":"25","author":"M Lopez-Dieguez","year":"2011","unstructured":"Lopez-Dieguez M, Montes ML, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, Tural C, Hernando A, Gonzalez-Garcia J, Serrano L, Arribas JR. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS. 2011;25:899\u2013904.","journal-title":"AIDS"},{"key":"1005_CR4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Macias","year":"2009","unstructured":"Macias J, Berenguer J, Japon MA, Giron JA, Rivero A, Lopez-Cortes LF, Moreno A, Gonzalez-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology. 2009;50:1056\u201363.","journal-title":"Hepatology"},{"key":"1005_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.26741","volume":"59","author":"MA Konerman","year":"2014","unstructured":"Konerman MA, Mehta SH, Sutcliffe CG, Vu T, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Fibrosis progression in human immunodeficiency virus\/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology. 2014;59:767\u201375.","journal-title":"Hepatology"},{"key":"1005_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/588669","volume":"47","author":"S Pol","year":"2008","unstructured":"Pol S, Soriano V. Management of chronic hepatitis C virus infection in HIV-infected patients. Clin Infect Dis. 2008;47:94\u2013101.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1005_CR7","first-page":"2","volume":"32","author":"European Association of the Study of the Liver","year":"2012","unstructured":"European Association of the Study of the Liver. 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines. Liver Int. 2012;32(Suppl 1):2\u20138.","journal-title":"Liver Int"},{"key":"1005_CR8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QCO.0b013e32835635df","volume":"25","author":"S Resino","year":"2012","unstructured":"Resino S, Sanchez-Conde M, Berenguer J. Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis. Curr Opin Infect Dis. 2012;25:564\u20139.","journal-title":"Curr Opin Infect Dis"},{"key":"1005_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"},{"key":"1005_CR10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335\u201374.","journal-title":"Hepatology"},{"issue":"1324\u20131334","key":"1005_CR11","first-page":"e1323","volume":"142","author":"S Naggie","year":"2012","unstructured":"Naggie S, Sulkowski MS. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology. 2012;142(1324\u20131334):e1323.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"1005_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/liv.12721","volume":"35","author":"JK Rockstroh","year":"2015","unstructured":"Rockstroh JK. Optimal therapy of HIV\/HCV co-infected patients with direct acting antivirals. Liver Int. 2015;35(Suppl 1):51\u20135.","journal-title":"Liver Int"},{"key":"1005_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.09.004","volume":"63","author":"J Pawlotsky","year":"2015","unstructured":"Pawlotsky J, Aghemo A, Back D, Dusheiko G, Forns X, Puoti M, Sarrazin C. EASL recommendations on treatment of Hepatitis C 2015. J Hepatol. 2015;63:199\u2013236.","journal-title":"J Hepatol"},{"key":"1005_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fimmu.2013.00343","volume":"4","author":"M Santa-Marta","year":"2013","unstructured":"Santa-Marta M, de Brito PM, Godinho-Santos A, Goncalves J. Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches. Front Immunol. 2013;4:343.","journal-title":"Front Immunol"},{"key":"1005_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/cmi.2014.131","volume":"13","author":"C Yang","year":"2016","unstructured":"Yang C, Zhao X, Sun D, Yang L, Chong C, Pan Y, Chi X, Gao Y, Wang M, Shi X, Sun H, Lv J, Zhong J, Niu J, Sun B. Interferon alpha (IFNalpha)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. Cell Mol Immunol. 2016;13:94\u2013102.","journal-title":"Cell Mol Immunol"},{"key":"1005_CR16","doi-asserted-by":"crossref","first-page":"e4894","DOI":"10.1371\/journal.pone.0004894","volume":"4","author":"L Carthagena","year":"2009","unstructured":"Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. Human TRIM gene expression in response to interferons. PLoS One. 2009;4:e4894.","journal-title":"PLoS One"},{"key":"1005_CR17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/eji.200737916","volume":"38","author":"R Rajsbaum","year":"2008","unstructured":"Rajsbaum R, Stoye JP, O\u2019Garra A. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur J Immunol. 2008;38:619\u201330.","journal-title":"Eur J Immunol"},{"key":"1005_CR18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"1005_CR19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3:799\u2013808.","journal-title":"Nat Rev Microbiol"},{"key":"1005_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/JVI.02496-15","volume":"90","author":"J Lascano","year":"2015","unstructured":"Lascano J, Uchil PD, Mothes W, Luban J. TRIM5 retroviral restriction activity correlates with the ability to induce innate immune signaling. J Virol. 2015;90:308\u201316.","journal-title":"J Virol"},{"key":"1005_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature09976","volume":"472","author":"T Pertel","year":"2011","unstructured":"Pertel T, Hausmann S, Morger D, Z\u00fcger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Gr\u00fctter MG, Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature. 2011;472:361\u20135.","journal-title":"Nature"},{"key":"1005_CR22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jmv.23985","volume":"86","author":"F Sadeghi","year":"2014","unstructured":"Sadeghi F, Bokharaei-Salim F, Salehi-Vaziri M, Monavari SH, Alavian SM, Salimi S, Vahabpour R, Keyvani H. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNalpha-2a and ribavirin in Iranian patients with chronic hepatitis C. J Med Virol. 2014;86:1499\u2013506.","journal-title":"J Med Virol"},{"key":"1005_CR23","doi-asserted-by":"crossref","first-page":"e1000007","DOI":"10.1371\/journal.ppat.1000007","volume":"4","author":"SD Barr","year":"2008","unstructured":"Barr SD, Smiley JR, Bushman FD. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 2008;4:e1000007.","journal-title":"PLoS Pathog"},{"key":"1005_CR24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JVI.01810-10","volume":"85","author":"R Singh","year":"2011","unstructured":"Singh R, Gaiha G, Werner L, McKim K, Mlisana K, Luban J, Walker BD, Karim SS, Brass AL, Ndung\u2019u T, Team CAIS. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J Virol. 2011;85:208\u201316.","journal-title":"J Virol"},{"issue":"6","key":"1005_CR25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jmv.24419","volume":"88","author":"JW Zhu","year":"2015","unstructured":"Zhu JW, Liu FL, Mu D, Deng DY, Zheng YT. Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients. J Med Virol. 2015;88(6):987\u201395.","journal-title":"J Med Virol"},{"key":"1005_CR26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.23011","volume":"50","author":"B Gao","year":"2009","unstructured":"Gao B, Duan Z, Xu W, Xiong S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology. 2009;50:424\u201333.","journal-title":"Hepatology"},{"key":"1005_CR27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/apt.12717","volume":"39","author":"AF Stattermayer","year":"2014","unstructured":"Stattermayer AF, Scherzer T, Beinhardt S, Rutter K, Hofer H, Ferenci P. Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther. 2014;39:1059\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"1005_CR28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-11-6","volume":"11","author":"MA Jimenez-Sousa","year":"2013","unstructured":"Jimenez-Sousa MA, Fernandez-Rodriguez A, Guzman-Fulgencio M, Garcia-Alvarez M, Resino S. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med. 2013;11:6.","journal-title":"BMC Med"},{"key":"1005_CR29","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.ppat.0030197","volume":"3","author":"SL Sawyer","year":"2007","unstructured":"Sawyer SL, Emerman M, Malik HS. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 2007;3:e197.","journal-title":"PLoS Pathog"},{"key":"1005_CR30","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/01.aids.0000432474.76873.5f","volume":"27","author":"S Ghezzi","year":"2013","unstructured":"Ghezzi S, Galli L, Kajaste-Rudnitski A, Turrini F, Marelli S, Toniolo D, Casoli C, Riva A, Poli G, Castagna A, Vicenzi E. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease. AIDS. 2013;27:2335\u201344.","journal-title":"AIDS"},{"key":"1005_CR31","doi-asserted-by":"crossref","first-page":"e12110","DOI":"10.5812\/hepatmon.12110","volume":"14","author":"N Zhao","year":"2014","unstructured":"Zhao N, Wang XL, Gu QH, Huang F, Zheng W, Li ZW. Tripartite motif-containing 22 gene -364T\/C polymorphism associated with hepatitis B virus infection in Chinese han population. Hepat Mon. 2014;14:e12110.","journal-title":"Hepat Mon"},{"key":"1005_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/649588","volume":"201","author":"IG Ovsyannikova","year":"2010","unstructured":"Ovsyannikova IG, Haralambieva IH, Dhiman N, O\u2019Byrne MM, Pankratz VS, Jacobson RM, Poland GA. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis. 2010;201:207\u201313.","journal-title":"J Infect Dis"},{"key":"1005_CR33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humimm.2013.01.031","volume":"74","author":"IG Ovsyannikova","year":"2013","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, O\u2019Byrne MM, Poland GA. Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity. Hum Immunol. 2013;74:768\u201374.","journal-title":"Hum Immunol"},{"key":"1005_CR34","first-page":"31. e31\u201331","volume":"28","author":"Panel de expertos de Gesida Plan Nacional sobre el Sida, Secretar\u00eda del Plan Nacional sobre el Sida (SPNS)\u00a0y Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH)","year":"2010","unstructured":"Panel de expertos de Gesida Plan Nacional sobre el Sida, Secretar\u00eda del Plan Nacional sobre el Sida (SPNS)\u00a0y Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH). Recommendations of Gesida\/PNS\/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus. Enferm Infecc Microbiol Clin. 2010;28:31. e31\u201331.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1005_CR35","doi-asserted-by":"crossref","unstructured":"Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, Curran JW. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis 1993;17(4):802\u201310.","DOI":"10.1093\/clinids\/17.4.802"},{"key":"1005_CR36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343\u201350.","journal-title":"Gastroenterology"},{"key":"1005_CR37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/gb-2013-14-1-201","volume":"14","author":"SJ O\u2019Brien","year":"2013","unstructured":"O\u2019Brien SJ, Hendrickson SL. Host genomic influences on HIV\/AIDS. Genome Biol. 2013;14:201.","journal-title":"Genome Biol"},{"key":"1005_CR38","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","volume":"61","author":"MH Heim","year":"2014","unstructured":"Heim MH, Thimme R. Innate and adaptive immune responses in HCV infections. J Hepatol. 2014;61:S14\u201325.","journal-title":"J Hepatol"},{"key":"1005_CR39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann F, Tacke F. Immunology in the liver\u2014from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13:88\u2013110.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1005_CR40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri3043","volume":"11","author":"C Jefferies","year":"2011","unstructured":"Jefferies C, Wynne C, Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol. 2011;11:617\u201325.","journal-title":"Nat Rev Immunol"},{"key":"1005_CR41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2011.05.124","volume":"410","author":"S Yu","year":"2011","unstructured":"Yu S, Gao B, Duan Z, Xu W, Xiong S. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-kappaB activator. Biochem Biophys Res Commun. 2011;410:247\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"1005_CR42","doi-asserted-by":"crossref","first-page":"153415","DOI":"10.1155\/2012\/153415","volume":"2012","author":"CJ Hattlmann","year":"2012","unstructured":"Hattlmann CJ, Kelly JN, Barr SD. TRIM22: a diverse and dynamic antiviral protein. Mol Biol Int. 2012;2012:153415.","journal-title":"Mol Biol Int"},{"key":"1005_CR43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/humu.22595","volume":"35","author":"JN Kelly","year":"2014","unstructured":"Kelly JN, Woods MW, Xhiku S, Barr SD. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function. Hum Mutat. 2014;35:1072\u201381.","journal-title":"Hum Mutat"},{"key":"1005_CR44","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/JVI.03603-13","volume":"88","author":"R Singh","year":"2014","unstructured":"Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, Luban J, Kasprowicz V, Dheda K, Abdool Karim SS, Ndung\u2019u T. TRIM5alpha and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. J Virol. 2014;88:4291\u2013303.","journal-title":"J Virol"},{"key":"1005_CR45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/humu.21349","volume":"31","author":"M Barenboim","year":"2010","unstructured":"Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Hum Mutat. 2010;31:1223\u201332.","journal-title":"Hum Mutat"},{"key":"1005_CR46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-60761-863-8_14","volume":"676","author":"D Landi","year":"2011","unstructured":"Landi D, Barale R, Gemignani F, Landi S. Prediction of the biological effect of polymorphisms within microRNA binding sites. Methods Mol Biol. 2011;676:197\u2013210.","journal-title":"Methods Mol Biol"},{"key":"1005_CR47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/BC20080104","volume":"101","author":"S Chatterjee","year":"2009","unstructured":"Chatterjee S, Pal JK. Role of 5\u2032- and 3\u2032-untranslated regions of mRNAs in human diseases. Biol Cell. 2009;101:251\u201362.","journal-title":"Biol Cell"},{"key":"1005_CR48","doi-asserted-by":"crossref","first-page":"D1033","DOI":"10.1093\/nar\/gkt1167","volume":"42","author":"L Guo","year":"2014","unstructured":"Guo L, Du Y, Chang S, Zhang K, Wang J. rSNPBase: a database for curated regulatory SNPs. Nucleic Acids Res. 2014;42:D1033\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1005_CR49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.22763","volume":"49","author":"M Heydtmann","year":"2009","unstructured":"Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology. 2009;49:676\u201388.","journal-title":"Hepatology"},{"issue":"577\u2013594","key":"1005_CR50","first-page":"e571","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(577\u2013594):e571.","journal-title":"Gastroenterology"},{"key":"1005_CR51","first-page":"1156","volume":"24","author":"J Maltby","year":"1996","unstructured":"Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 1996;24:1156\u201360.","journal-title":"Hepatology"},{"key":"1005_CR52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/apt.13389","volume":"42","author":"S Johansson","year":"2015","unstructured":"Johansson S, Talloen W, Tuefferd M, Darling JM, Scholliers A, Fanning G, Fried MW, Aerssens J. Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients. Aliment Pharmacol Ther. 2015;42:1111\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"1005_CR53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","volume":"25","author":"B Moser","year":"2004","unstructured":"Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004;25:75\u201384.","journal-title":"Trends Immunol"},{"key":"1005_CR54","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","volume":"105","author":"M Sarasin-Filipowicz","year":"2008","unstructured":"Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, Heim MH. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA. 2008;105:7034\u20139.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-1005-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:52:37Z","timestamp":1498326757000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-016-1005-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-1005-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]},"article-number":"257"}}